The Brazilian Patent and Trademark Office (BPTO) signed a new technical cooperation agreement with the Brazilian Association of the Pharmaceutical Inputs Industry (ABIQUIFI) during the BIO International Convention 2025, held from June 16 to 19 in Boston, United States.

BPTO’s president, Júlio César Moreira, participated in the 10th Summit Brazil, a side event to the convention, addressing the role of non-clinical research in the development of innovative medicines and therapies. During the event, the partnership between BPTO and ABIQUIFI was formalized.

The agreement aims to strengthen collaboration between BPTO and the Brazilian pharmaceutical sector by promoting joint actions for capacity building, technology development, and support for innovation. Planned initiatives include BPTO’s participation in ABIQUIFI-led programs, such as “Inovação Radical” (Radical Innovation), which supports startups and companies focused on solutions for rare and severe diseases, as well as training courses on technology pricing.

Additionally, ABIQUIFI will participate in BPTO-organized activities, including events targeting startups and biotech companies, as well as a mentorship program. The partnership aligns with the objectives of Brazil’s National Intellectual Property Strategy (ENPI), particularly Axis 01 (IP for Competitiveness and Development) and Axis 02 (IP Awareness, Training, and Capacity Building).

The BIO International Convention is recognized as one of the leading global events in biotechnology, attracting approximately 20,000 participants from companies, academia, governments, and investors, with a focus on partnership development and innovative solutions.